Digital Health

Will Virtual Care Survive the Medicare Funding Cliff?
Tech & Innovation Will Virtual Care Survive the Medicare Funding Cliff?

As the clock ticks toward October 1, the U.S. healthcare system braces for a pivotal moment that could reshape access to vital services for millions of Medicare beneficiaries, with key virtual care programs like telehealth flexibilities and the Acute Hospital Care at Home (AHCAH) waivers facing

Innovation Reshapes Pharma at DCAT Summit Lugano 2025
Biotech & Bioprocessing Innovation Reshapes Pharma at DCAT Summit Lugano 2025

The pharmaceutical industry stands at a critical juncture, where the urgent need for faster, more sustainable, and patient-focused solutions is driving unprecedented change, as vividly demonstrated at the DCAT Summit held on June 4–5 in Lugano, Switzerland. Under the compelling theme "Expedition

Health Tech Innovators Transform Cardiovascular Care
Tech & Innovation Health Tech Innovators Transform Cardiovascular Care

In a world where heart disease remains the leading cause of death, claiming millions of lives each year, a quiet revolution is unfolding that promises to change the landscape of medical care. Picture a patient in a remote rural area, unable to access a cardiologist, yet receiving personalized heart

Can Smartwatches Detect Heart Disease with AI Technology?
Tech & Innovation Can Smartwatches Detect Heart Disease with AI Technology?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in tech and innovation within the industry. With a strong background in research and development, Ivan has been at the forefront of integrating cutting-edge technologies into healthcare. Today, we’re

CareCloud's Valuation: Undervalued Gem or Investor Doubt?
Tech & Innovation CareCloud's Valuation: Undervalued Gem or Investor Doubt?

In the fast-paced world of healthcare technology, where innovation can turn a small player into a market leader overnight, CareCloud (CCLD) stands at a crossroads with its stock price languishing at $3.68 against a consensus fair value of $4.75. The company’s latest moves—such as the launch of the

How Can AI Safely Enhance Clinical Diagnosis?
Tech & Innovation How Can AI Safely Enhance Clinical Diagnosis?

Today, we’re thrilled to sit down with Ivan Kairatov, a distinguished expert in biopharma with a profound understanding of technology and innovation in the industry. With a robust background in research and development, Ivan has been at the forefront of exploring how artificial intelligence can

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later